Before you begin using a medication, be sure to inform your doctor of any medical conditions or Allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should use Vyzulta (Latanoprostene-bunod).
Eye changes: Latanoprostene may gradually change the colour of the eye, increasing the amount of brown pigment in the iris by increasing the number of melanosomes (pigment granules). The long-term effects on the eye and the chances of injury to the eye are currently unknown. The change in colour may be permanent. This effect has mostly been seen in patients with mixed-coloured eyes (e.g., blue-brown, grey-brown, green-brown, or yellow-brown). In patients with uniformly blue, grey, green, or brown eyes, the change has only rarely been seen. The change in colour occurs slowly, and may not be noticeable for several months to years. Latanoprostene has also been reported to cause darkening, thickening, and lengthening of eyelashes, as well as darkening of the eyelid.
Other eye conditions: The safety of using latanoprostene eye drops if you have other eye conditions may not be well known. If you have other eye conditions such as macular edema, uveitis or lens problems, or a history of herpetic keratitis, discuss with your doctor how latanoprostene may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Vyzulta (Latanoprostene-bunod), and whether any special monitoring is needed.
Kidney or liver function: Vyzulta (Latanoprostene-bunod) has not been studied for use by people with impaired kidney or liver function. If you have impaired kidney or liver function, discuss with your doctor how latanoprostene may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Vyzulta (Latanoprostene-bunod), and whether any special monitoring is needed.
Contact lenses: Remove contact lenses before instilling these eye drops. Lenses can be reinserted 15 minutes after using the eye drops.
Pregnancy: Vyzulta (Latanoprostene-bunod) should not be used during pregnancy unless the benefits outweigh the risks. If you become pregnant while taking Vyzulta (Latanoprostene-bunod), contact your doctor immediately.
Breast-feeding: Vyzulta (Latanoprostene-bunod) may pass into breast milk. If you are a breast-feeding mother and are taking latanoprostene, it may affect your baby. Talk to your doctor about whether you should continue breast-feeding.
Children: The safety and effectiveness of using Vyzulta (Latanoprostene-bunod) have not been established for children and adolescents less than 16 years of age.